European Archives - Page 975 of 1054 - European Medical Journal

EMJ

Siemens Solutions Support Diagnosis and Treatment of Cardiovascular Diseases

Cardiovascular diseases such as heart attack, stroke, and coronary heart disease have been among the most common causes of death worldwide for many years…

EMJ

PTSD in Vietnam War Veterans Reveals Lifelong Impact of Combat Service

AMERICAN veterans of the Vietnam War continue to experience post-traumatic stress disorder (PTSD) and other mental health illnesses despite…

EMJ

Schizophrenia: Identification of ‘Rosetta Stone’ Gene

DISCOVERY of a key role for the protein ‘disrupted in schizophrenia 1’ (DISC1) during a critical period of neural development shortly after birth may…

EMJ

Janssen Submits European Extension Marketing Authorisation Application for Paliperidone Palmitate Once-Every-Three-Months Formulation

BEERSE, Belgium, 21st August 2015 – Janssen-Cilag International NV (Janssen) today announced the submission of an Extension Marketing Authorisation…

EMJ

Registry evaluating the impact of genomic testing on treatment of prostate cancer patients

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, discusses…

EMJ

CancerLinQ: ASCO’s initiative to improve patient care through big data

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, Omaha, NE…

EMJ

ARAMIS trial of ODM-201 for high-risk non-metastatic castration-resistant prostate cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, discusses…

EMJ

Immune checkpoint inhibitors and biomarker-driven strategies for managing lung cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen…

EMJ

An update on the treatment of chronic lymphocytic leukaemia

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Stephan Stilgenbauer, MD, of Ulm University, Ulm, Germany, reviews the changing…

EMJ

HELIOS: Phase 3 trial of ibrutinib with bendamustine and rituximab for relapsed/refractory CLL

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jacqueline Barrientos, MD, of North Shore-LIJ Cancer Institute, Lake Success, NY…